Evidence map›Paper›PMID 36978695›Full record

ArticleBioengineering (Basel, Switzerland)2023

An Integrated In Vivo/In Vitro Protein Production Platform for Site-Specific Antibody Drug Conjugates.

Jeffrey Hanson, Dan Groff, Abi Carlos, Hans Usman, Kevin Fong, Abigail Yu, Stephanie Armstrong, Allison Dwyer, Mary Rose Masikat, Dawei Yuan and 6 more

Open access · goldFull text read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. BeyondChemical reviews · 2025
    Review
  5. Cell-free protein synthesis platforms for accelerating drug discovery.Biotechnology notes (Amsterdam, Netherlands) · 2025
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 1 institution in 1 country.

Jeffrey HansonSutro Biopharma Inc., 111 Oyster Point, South San Francisco, CA 94080, USA.ORCID 0000-0003-4381-2589
Dan GroffSutro Biopharma Inc., 111 Oyster Point, South San Francisco, CA 94080, USA.
Abi CarlosSutro Biopharma Inc., 111 Oyster Point, South San Francisco, CA 94080, USA.
Hans UsmanSutro Biopharma Inc., 111 Oyster Point, South San Francisco, CA 94080, USA.
Kevin FongSutro Biopharma Inc., 111 Oyster Point, South San Francisco, CA 94080, USA.
Abigail YuSutro Biopharma Inc., 111 Oyster Point, South San Francisco, CA 94080, USA.
Stephanie ArmstrongSutro Biopharma Inc., 111 Oyster Point, South San Francisco, CA 94080, USA.
Allison DwyerSutro Biopharma Inc., 111 Oyster Point, South San Francisco, CA 94080, USA.
Mary Rose MasikatSutro Biopharma Inc., 111 Oyster Point, South San Francisco, CA 94080, USA.
Dawei YuanSutro Biopharma Inc., 111 Oyster Point, South San Francisco, CA 94080, USA.
Cuong TranSutro Biopharma Inc., 111 Oyster Point, South San Francisco, CA 94080, USA.
Tyler HeibeckSutro Biopharma Inc., 111 Oyster Point, South San Francisco, CA 94080, USA.
James ZawadaSutro Biopharma Inc., 111 Oyster Point, South San Francisco, CA 94080, USA.
Rishard ChenSutro Biopharma Inc., 111 Oyster Point, South San Francisco, CA 94080, USA.
Trevor HallamSutro Biopharma Inc., 111 Oyster Point, South San Francisco, CA 94080, USA.
Gang YinSutro Biopharma Inc., 111 Oyster Point, South San Francisco, CA 94080, USA.
Sutro Biopharma (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The XpressCF+

Indexed as

antibody drug conjugatecell-free manufacturingcell-free protein synthesisE. coli expressionlight chainsite-specific ACDstiter improvement

Identifiers

PMID36978695
PMCPMC10045668
OpenAlexW4322619928

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read79
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.